Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2025-12-25 @ 2:30 AM
NCT ID:
NCT01016834
Eligibility Criteria:
Inclusion Criteria:
* History of 2 to 6 migraine headaches per month
* Migraines should have been present for at least 1 year with age at onset of migraine less than 50 years
* History of 24 hours of freedom between migraine attacks
* Current users of triptan medications
* Able to distinguish interval or other non-migrainous headaches from typical migraine
* General good health
Exclusion Criteria:
* History or symptoms, or signs of ischemic cardiac, cerebrovascular, or peripheral vascular syndromes
* Significant underlying cardiovascular diseases including uncontrolled hypertension
* Hemiplegic or basilar migraine
* History or diagnosis of severe hepatic or renal impairment
* History of epilepsy or seizure or other serious neurologic condition
* History of allergy, anaphylaxis, or hypersensitivity to sumatriptan or any of its components or similar drugs including sulphonamides
* History of scleroderma (systemic sclerosis)
* Pregnant or breastfeeding
* Use of contraindicated prescription medications, monoamine oxidase inhibitors (MAO-A), selective serotonin reuptake inhibitors, or lithium agents
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT01016834
Study Brief:
Protocol Section:
NCT01016834